140 related articles for article (PubMed ID: 16158288)
1. Immunohistochemical demonstration of histone H1(0) in human breast carcinoma.
Kostova NN; Srebreva LN; Milev AD; Bogdanova OG; Rundquist I; Lindner HH; Markov DV
Histochem Cell Biol; 2005 Nov; 124(5):435-43. PubMed ID: 16158288
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
3. Expression of hyaluronan in benign and malignant breast lesions.
Auvinen PK; Parkkinen JJ; Johansson RT; Agren UM; Tammi RH; Eskelinen MJ; Kosma VM
Int J Cancer; 1997 Oct; 74(5):477-81. PubMed ID: 9355968
[TBL] [Abstract][Full Text] [Related]
4. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
6. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
Pilichowska M; Kimura N; Fujiwara H; Nagura H
Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
[TBL] [Abstract][Full Text] [Related]
8. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
9. p53 protein expression in benign and malignant breast lesions.
Ioakim-Liossi A; Markopoulos C; Karakitsos P; Safioleas M; Gogas J; Vaiopoulos G
Acta Cytol; 1998; 42(4):918-22. PubMed ID: 9684577
[TBL] [Abstract][Full Text] [Related]
10. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar organizer regions in human breast cancer.
Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
[TBL] [Abstract][Full Text] [Related]
13. Expression of nuclear insulin receptor substrate 1 in breast cancer.
Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of proCOL11A1 as a stromal marker of breast cancer.
Fuentes-Martínez N; García-Pravia C; García-Ocaña M; Menéndez-Rodríguez P; Del Amo J; Suárez-Fernández L; Galván JA; De los Toyos JR; Barneo L
Histol Histopathol; 2015 Jan; 30(1):87-93. PubMed ID: 25005174
[TBL] [Abstract][Full Text] [Related]
15. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
16. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
17. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
19. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
20. p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Rosen PP; Lesser ML; Arroyo CD; Cranor M; Borgen P; Norton L
J Clin Oncol; 1995 Apr; 13(4):821-30. PubMed ID: 7707107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
